{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:16:25Z","timestamp":1793823385411,"version":"4.6.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1245\/s10434-020-08220-3","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T16:02:59Z","timestamp":1582905779000},"page":"1329-1337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine\/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma"],"prefix":"10.1245","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5744-568X","authenticated-orcid":false,"given":"Dhaval","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Phay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina W. F.","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paxton V.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen C.","family":"Sol\u00f3rzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence T.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,28]]},"reference":[{"key":"8220_CR1","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915\u201342.","journal-title":"J Clin Endocrinol Metab."},{"key":"8220_CR2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366:665\u201375.","journal-title":"Lancet"},{"key":"8220_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5347(17)37119-7","volume":"147","author":"RK Whalen","year":"1992","unstructured":"Whalen RK, Althausen AF, Daniels GH. Extra-adrenal pheochromocytoma. J Urol. 1992;147:1\u201310.","journal-title":"J Urol."},{"key":"8220_CR4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7326\/0003-4819-134-4-200102200-00016","volume":"134","author":"K Pacak","year":"2001","unstructured":"Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med. 2001;134:315\u201329.","journal-title":"Ann Intern Med."},{"key":"8220_CR5","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1083\/jcb.200302075","volume":"161","author":"L Dailey","year":"2003","unstructured":"Dailey L, Laplantine E, Priore R, Basilico C. A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J Cell Biol. 2003;161:1053\u201366.","journal-title":"J Cell Biol."},{"key":"8220_CR6","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.athoracsur.2012.02.040","volume":"93","author":"B Ramlawi","year":"2012","unstructured":"Ramlawi B, David EA, Kim MP, et al. Contemporary surgical management of cardiac paragangliomas. Ann Thorac Surg. 2012;93:1972\u20136.","journal-title":"Ann Thorac Surg."},{"key":"8220_CR7","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.athoracsur.2008.04.105","volume":"86","author":"ML Brown","year":"2008","unstructured":"Brown ML, Zayas GE, Abel MD, Young WF Jr, Schaff HV. Mediastinal paragangliomas: the Mayo Clinic experience. Ann Thorac Surg. 2008;86:946\u201351.","journal-title":"Ann Thorac Surg."},{"key":"8220_CR8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ki.1991.244","volume":"40","author":"EL Bravo","year":"1991","unstructured":"Bravo EL. Pheochromocytoma: new concepts and future trends. Kidney Int. 1991;40:544\u201356.","journal-title":"Kidney Int."},{"key":"8220_CR9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2559.2010.03613.x","volume":"58","author":"AM McNicol","year":"2011","unstructured":"McNicol AM. Update on tumours of the adrenal cortex, phaeochromocytoma, and extra-adrenal paraganglioma. Histopathology. 2011;58:155\u201368.","journal-title":"Histopathology"},{"key":"8220_CR10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/MPA.0b013e3181ebb4f0","volume":"39","author":"H Chen","year":"2010","unstructured":"Chen H, Sippel RS, O\u2019Dorisio MS, et al. The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas. 2010;39:775\u201383.","journal-title":"Pancreas"},{"key":"8220_CR11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0002-9610(00)00296-8","volume":"179","author":"CY Lo","year":"2000","unstructured":"Lo CY, Lam KY, Wat MS, Lam KS. Adrenal pheochromocytoma remains a frequently overlooked diagnosis. Am J Surg. 2000;179:212\u20135.","journal-title":"Am J Surg."},{"key":"8220_CR12","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1445-5994.2000.tb04358.x","volume":"30","author":"AR McNeil","year":"2000","unstructured":"McNeil AR, Blok BH, Koelmeyer TD, Burke MP, Hilton JM. Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne, and Auckland. Aust N Z J Med. 2000;30:648\u201352.","journal-title":"Aust N Z J Med."},{"key":"8220_CR13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00004872-199405000-00015","volume":"12","author":"GH Anderson Jr","year":"1994","unstructured":"Anderson GH Jr, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens. 1994;12:609\u201315.","journal-title":"J Hypertens."},{"key":"8220_CR14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4158\/EP.6.3.249","volume":"6","author":"M Ariton","year":"2000","unstructured":"Ariton M, Juan CS, AvRuskin TW. Pheochromocytoma: clinical observations from a Brooklyn tertiary hospital. Endocr Pract. 2000;6:249\u201352.","journal-title":"Endocr Pract."},{"key":"8220_CR15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1651-2227.1992.tb12213.x","volume":"81","author":"T Wyszynska","year":"1992","unstructured":"Wyszynska T, Cichocka E, Wieteska-Klimczak A, Jobs K, Januszewicz P. A single pediatric center experience with 1025 children with hypertension. Acta Paediatr. 1992;81:244\u20136.","journal-title":"Acta Paediatr."},{"key":"8220_CR16","first-page":"637","volume":"85","author":"F Mantero","year":"2000","unstructured":"Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab. 2000;85:637\u201344.","journal-title":"J Clin Endocrinol Metab."},{"key":"8220_CR17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2002-0031","volume":"25","author":"G Mansmann","year":"2004","unstructured":"Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev. 2004;25:309\u201340.","journal-title":"Endocr Rev."},{"key":"8220_CR18","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/jnci\/djg024","volume":"95","author":"J Bryant","year":"2003","unstructured":"Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL. Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst. 2003;95:1196\u2013204.","journal-title":"J Natl Cancer Inst."},{"key":"8220_CR19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1530\/eje.0.1500681","volume":"150","author":"JP Baguet","year":"2004","unstructured":"Baguet JP, Hammer L, Mazzuco TL, et al. Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. Eur J Endocrinol. 2004;150:681\u20136.","journal-title":"Eur J Endocrinol."},{"key":"8220_CR20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/EJE-09-0384","volume":"161","author":"R Kopetschke","year":"2009","unstructured":"Kopetschke R, Slisko M, Kilisli A, et al. Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. Eur J Endocrinol. 2009;161:355\u201361.","journal-title":"Eur J Endocrinol."},{"key":"8220_CR21","doi-asserted-by":"crossref","first-page":"684","DOI":"10.2214\/ajr.185.3.01850684","volume":"185","author":"GA Motta-Ramirez","year":"2005","unstructured":"Motta-Ramirez GA, Remer EM, Herts BR, Gill IS, Hamrahian AH. Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. AJR Am J Roentgenol. 2005;185:684\u20138.","journal-title":"AJR Am J Roentgenol."},{"key":"8220_CR22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0895-7061(99)00139-9","volume":"13","author":"T Noshiro","year":"2000","unstructured":"Noshiro T, Shimizu K, Watanabe T, et al. Changes in clinical features and long-term prognosis in patients with pheochromocytoma. Am J Hypertens. 2000;13:35\u201343.","journal-title":"Am J Hypertens."},{"key":"8220_CR23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jamcollsurg.2009.09.022","volume":"209","author":"MA Guerrero","year":"2009","unstructured":"Guerrero MA, Schreinemakers JM, Vriens MR, et al. Clinical spectrum of pheochromocytoma. J Am Coll Surg. 2009;209:727\u201332.","journal-title":"J Am Coll Surg."},{"key":"8220_CR24","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/01.HYP.29.5.1133","volume":"29","author":"PF Plouin","year":"1997","unstructured":"Plouin PF, Chatellier G, Fofol I, Corvol P. Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension. 1997;29:1133\u20139.","journal-title":"Hypertension"},{"key":"8220_CR25","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1210\/jc.2017-00992","volume":"102","author":"O Hamidi","year":"2017","unstructured":"Hamidi O, Young WF Jr, Iniguez-Ariza NM, et al. Malignant pheochromocytoma and paraganglioma: 272 patients over 55 years. J Clin Endocrinol Metab. 2017;102:3296\u2013305.","journal-title":"J Clin Endocrinol Metab."},{"key":"8220_CR26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/A:1011572617314","volume":"2","author":"G Eisenhofer","year":"2001","unstructured":"Eisenhofer G, Huynh TT, Hiroi M, Pacak K. Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma. Rev Endocr Metab Disord. 2001;2:297\u2013311.","journal-title":"Rev Endocr Metab Disord."},{"key":"8220_CR27","first-page":"1480","volume":"86","author":"PF Plouin","year":"2001","unstructured":"Plouin PF, Duclos JM, Soppelsa F, Boublil G, Chatellier G. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab. 2001;86:1480\u20136.","journal-title":"J Clin Endocrinol Metab."},{"key":"8220_CR28","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/HJH.0b013e32834a4ce9","volume":"29","author":"A Prejbisz","year":"2011","unstructured":"Prejbisz A, Lenders JW, Eisenhofer G, Januszewicz A. Cardiovascular manifestations of phaeochromocytoma. J Hypertens. 2011;29:2049\u201360.","journal-title":"J Hypertens."},{"key":"8220_CR29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-0032-1306294","volume":"44","author":"T Zelinka","year":"2012","unstructured":"Zelinka T, Petrak O, Turkova H, et al. High incidence of cardiovascular complications in pheochromocytoma. Horm Metab Res. 2012;44:379\u201384.","journal-title":"Horm Metab Res."},{"key":"8220_CR30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM196002252620805","volume":"262","author":"S Brunjes","year":"1960","unstructured":"Brunjes S, Johns VJ Jr, Crane MG. Pheochromocytoma: postoperative shock and blood volume. N Engl J Med. 1960;262:393\u20136.","journal-title":"N Engl J Med."},{"key":"8220_CR31","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/00004872-200309000-00020","volume":"21","author":"A La Batide-Alanore","year":"2003","unstructured":"La Batide-Alanore A, Chatellier G, Plouin PF. Diabetes as a marker of pheochromocytoma in hypertensive patients. J Hypertens. 2003;21:1703\u20137.","journal-title":"J Hypertens."},{"key":"8220_CR32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/jcem-49-3-322","volume":"49","author":"M Hamaji","year":"1979","unstructured":"Hamaji M. Pancreatic alpha- and beta-cell function in pheochromocytoma. J Clin Endocrinol Metab. 1979;49:322\u20135.","journal-title":"J Clin Endocrinol Metab."},{"key":"8220_CR33","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-51-4-930","volume":"51","author":"DM Turnbull","year":"1980","unstructured":"Turnbull DM, Johnston DG, Alberti KG, Hall R. Hormonal and metabolic studies in a patient with a pheochromocytoma. J Clin Endocrinol Metab. 1980;51:930\u20133.","journal-title":"J Clin Endocrinol Metab."},{"key":"8220_CR34","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1365-2044.1983.tb12258.x","volume":"38","author":"FJ Gilsanz","year":"1983","unstructured":"Gilsanz FJ, Luengo C, Conejero P, Peral P, Avello F. Cardiomyopathy and phaeochromocytoma. Anaesthesia. 1983;38:888\u201391.","journal-title":"Anaesthesia"},{"key":"8220_CR35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2012-3020","volume":"98","author":"A Scholten","year":"2013","unstructured":"Scholten A, Cisco RM, Vriens MR, et al. Pheochromocytoma crisis is not a surgical emergency. J Clin Endocr Metab. 2013;98:581\u201391.","journal-title":"J Clin Endocr Metab."},{"key":"8220_CR36","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/archsurg.1988.01400320042007","volume":"123","author":"KA Newell","year":"1988","unstructured":"Newell KA, Prinz RA, Pickleman J, et al. Pheochromocytoma multisystem crisis: a surgical emergency. Arch Surg. 1988;123:956\u20139.","journal-title":"Arch Surg."},{"key":"8220_CR37","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1634\/theoncologist.2008-0043","volume":"13","author":"JT Adler","year":"2008","unstructured":"Adler JT, Meyer-Rochow GY, Chen H, et al. Pheochromocytoma: current approaches and future directions. Oncologist. 2008;13:779\u201393.","journal-title":"Oncologist"},{"key":"8220_CR38","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1210\/jc.2007-1720","volume":"92","author":"K Pacak","year":"2007","unstructured":"Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92:4069\u201379.","journal-title":"J Clin Endocrinol Metab."},{"key":"8220_CR39","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1210\/jc.2013-1844","volume":"98","author":"M Haissaguerre","year":"2013","unstructured":"Haissaguerre M, Courel M, Caron P, et al. Normotensive incidentally discovered pheochromocytomas display specific biochemical, cellular, and molecular characteristics. J Clin Endocrinol Metab. 2013;98:4346\u201354.","journal-title":"J Clin Endocrinol Metab."},{"key":"8220_CR40","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jcem.86.5.7496","volume":"86","author":"G Eisenhofer","year":"2001","unstructured":"Eisenhofer G, Walther MM, Huynh TT, et al. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab. 2001;86:1999\u20132008.","journal-title":"J Clin Endocrinol Metab."},{"key":"8220_CR41","first-page":"69","volume":"38","author":"G Eisenhofer","year":"2017","unstructured":"Eisenhofer G, Klink B, Richter S, Lenders JW, Robledo M. Metabologenomics of phaeochromocytoma and paraganglioma: an integrated approach for personalised biochemical and genetic testing. Clin Biochem Rev. 2017;38:69\u2013100.","journal-title":"Clin Biochem Rev."},{"key":"8220_CR42","doi-asserted-by":"crossref","first-page":"e2198","DOI":"10.1097\/MD.0000000000002198","volume":"94","author":"M Batisse-Lignier","year":"2015","unstructured":"Batisse-Lignier M, Pereira B, Motreff P, et al. Acute and chronic pheochromocytoma-induced cardiomyopathies: different prognoses? A systematic analytical review. Med Baltim. 2015;94:e2198.","journal-title":"Med Baltim."},{"key":"8220_CR43","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4158\/EP171930.OR","volume":"23","author":"N Gagnon","year":"2017","unstructured":"Gagnon N, Mansour S, Bitton Y, Bourdeau I. Takotsubo-like cardiomyopathy in a large cohort of patients with pheochromocytoma and paraganglioma. Endocr Pract. 2017;23:1178\u201392.","journal-title":"Endocr Pract."},{"key":"8220_CR44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijcard.2017.07.014","volume":"249","author":"R Zhang","year":"2017","unstructured":"Zhang R, Gupta D, Albert SG. Pheochromocytoma as a reversible cause of cardiomyopathy: analysis and review of the literature. Int J Cardiol. 2017;249:319\u201323.","journal-title":"Int J Cardiol."},{"key":"8220_CR45","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/0006-3002(57)90491-2","volume":"25","author":"MD Armstrong","year":"1957","unstructured":"Armstrong MD, Mc MA, Shaw KN. 3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine. Biochim Biophys Acta. 1957;25:422\u20133.","journal-title":"Biochim Biophys Acta"},{"key":"8220_CR46","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM197909273011302","volume":"301","author":"EL Bravo","year":"1979","unstructured":"Bravo EL, Tarazi RC, Gifford RW, Stewart BH. Circulating and urinary catecholamines in pheochromocytoma: diagnostic and pathophysiologic implications. N Engl J Med. 1979;301:682\u20136.","journal-title":"N Engl J Med."},{"key":"8220_CR47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-123-2-199507150-00004","volume":"123","author":"JW Lenders","year":"1995","unstructured":"Lenders JW, Keiser HR, Goldstein DS, et al. Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med. 1995;123:101\u20139.","journal-title":"Ann Intern Med."},{"key":"8220_CR48","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0029-1237699","volume":"118","author":"R Yu","year":"2010","unstructured":"Yu R, Wei M. False-positive test results for pheochromocytoma from 2000 to 2008. Exp Clin Endocrinol Diabetes. 2010;118:577\u201385.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"8220_CR49","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","volume":"88","author":"G Eisenhofer","year":"2003","unstructured":"Eisenhofer G, Goldstein DS, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab. 2003;88:2656\u201366.","journal-title":"J Clin Endocrinol Metab."},{"key":"8220_CR50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MED.0b013e32835fcc45","volume":"20","author":"A Vicha","year":"2013","unstructured":"Vicha A, Musil Z, Pacak K. Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options. Curr Opin Endocrinol Diabetes Obes. 2013;20:186\u201391.","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"key":"8220_CR51","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3389\/fendo.2018.00515","volume":"9","author":"R Alrezk","year":"2018","unstructured":"Alrezk R, Suarez A, Tena I, Pacak K. Update of pheochromocytoma syndromes: genetics, biochemical evaluation, and imaging. Front Endocrinol Lausanne. 2018;9:515.","journal-title":"Front Endocrinol Lausanne"},{"key":"8220_CR52","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gim.2014.147","volume":"17","author":"H Hampel","year":"2015","unstructured":"Hampel H, Bennett RL, Buchanan A, et al. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Genet Med. 2015;17:70\u201387.","journal-title":"Genet Med."},{"key":"8220_CR53","doi-asserted-by":"crossref","first-page":"T201","DOI":"10.1530\/ERC-18-0085","volume":"25","author":"HP Neumann","year":"2018","unstructured":"Neumann HP, Young WF Jr, Krauss T, et al. 65\u00a0Years of the double helix: genetics informs precision practice in the diagnosis and management of pheochromocytoma. Endocr Relat Cancer. 2018;25:T201\u201319.","journal-title":"Endocr Relat Cancer"},{"key":"8220_CR54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.trecan.2017.11.001","volume":"4","author":"I Jochmanova","year":"2018","unstructured":"Jochmanova I, Pacak K. Genomic landscape of pheochromocytoma and paraganglioma. Trends Cancer. 2018;4:6\u20139.","journal-title":"Trends Cancer"},{"key":"8220_CR55","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.surg.2016.05.050","volume":"161","author":"Y Assadipour","year":"2017","unstructured":"Assadipour Y, Sadowski SM, Alimchandani M, et al. SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma. Surgery. 2017;161:230\u20139.","journal-title":"Surgery"},{"key":"8220_CR56","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M, et al. von Hippel\u2013Lindau disease. Lancet. 2003;361:2059\u201367.","journal-title":"Lancet"},{"key":"8220_CR57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/ERC-13-0415","volume":"21","author":"B Bausch","year":"2014","unstructured":"Bausch B, Wellner U, Bausch D, et al. Long-term prognosis of patients with pediatric pheochromocytoma. Endocr Relat Cancer. 2014;21:17\u201325.","journal-title":"Endocr Relat Cancer"},{"key":"8220_CR58","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.3747\/co.21.1579","volume":"21","author":"M Lefebvre","year":"2014","unstructured":"Lefebvre M, Foulkes WD. Pheochromocytoma and paraganglioma syndromes: genetics and management update. Curr Oncol. 2014;21:e8\u201317.","journal-title":"Curr Oncol."},{"key":"8220_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2017.05.010","volume":"67","author":"MM Miettinen","year":"2017","unstructured":"Miettinen MM, Antonescu CR, Fletcher CDM, et al. Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1: a consensus overview. Hum Pathol. 2017;67:1\u201310.","journal-title":"Hum Pathol."},{"key":"8220_CR60","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0033","volume":"174","author":"PF Plouin","year":"2016","unstructured":"Plouin PF, Amar L, Dekkers OM, et al. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol. 2016;174:G1\u201310.","journal-title":"Eur J Endocrinol."},{"key":"8220_CR61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.surg.2017.05.025","volume":"163","author":"P Nockel","year":"2018","unstructured":"Nockel P, El Lakis M, Gaitanidis A, et al. Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery. Surgery. 2018;163:191\u20136.","journal-title":"Surgery"},{"key":"8220_CR62","doi-asserted-by":"crossref","unstructured":"Group NGSiPS, Toledo RA, Burnichon N, et al. Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nat Rev Endocrinol. 2017;13:233\u201347.","DOI":"10.1038\/nrendo.2016.185"},{"key":"8220_CR63","doi-asserted-by":"crossref","first-page":"T135","DOI":"10.1530\/ERC-15-0175","volume":"22","author":"F Castinetti","year":"2015","unstructured":"Castinetti F, Kroiss A, Kumar R, Pacak K, Taieb D. 15 Years of paraganglioma: imaging and imaging-based treatment of pheochromocytoma and paraganglioma. Endocr Relat Cancer. 2015;22:T135\u201345.","journal-title":"Endocr Relat Cancer."},{"key":"8220_CR64","first-page":"3151","volume":"15","author":"F Ctvrtlik","year":"2018","unstructured":"Ctvrtlik F, Koranda P, Schovanek J, Skarda J, Hartmann I, Tudos Z. Current diagnostic imaging of pheochromocytomas and implications for therapeutic strategy. Exp Ther Med. 2018;15:3151\u201360.","journal-title":"Exp Ther Med."},{"key":"8220_CR65","first-page":"153","volume":"12","author":"JC Baez","year":"2012","unstructured":"Baez JC, Jagannathan JP, Krajewski K, et al. Pheochromocytoma and paraganglioma: imaging characteristics. Cancer Imaging. 2012;12:153\u201362.","journal-title":"Cancer Imaging"},{"key":"8220_CR66","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/RCT.0b013e3181d529f2","volume":"34","author":"KM Elsayes","year":"2010","unstructured":"Elsayes KM, Menias CO, Siegel CL, Narra VR, Kanaan Y, Hussain HK. Magnetic resonance characterization of pheochromocytomas in the abdomen and pelvis: imaging findings in 18 surgically proven cases. J Comput Assist Tomogr. 2010;34:548\u201353.","journal-title":"J Comput Assist Tomogr."},{"key":"8220_CR67","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2214\/AJR.05.0370","volume":"187","author":"KY Lee","year":"2006","unstructured":"Lee KY, Oh YW, Noh HJ, et al. Extraadrenal paragangliomas of the body: imaging features. AJR Am J Roentgenol. 2006;187:492\u2013504.","journal-title":"AJR Am J Roentgenol."},{"key":"8220_CR68","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3174\/ajnr.A0948","volume":"29","author":"F Neves","year":"2008","unstructured":"Neves F, Huwart L, Jourdan G, et al. Head and neck paragangliomas: value of contrast-enhanced 3D MR angiography. AJNR Am J Neuroradiol. 2008;29:883\u20139.","journal-title":"AJNR Am J Neuroradiol."},{"key":"8220_CR69","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2214\/ajr.148.1.201","volume":"148","author":"WL Olsen","year":"1987","unstructured":"Olsen WL, Dillon WP, Kelly WM, Norman D, Brant-Zawadzki M, Newton TH. MR imaging of paragangliomas. AJR Am J Roentgenol. 1987;148:201\u20134.","journal-title":"AJR Am J Roentgenol."},{"key":"8220_CR70","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2265.2008.03256.x","volume":"69","author":"KS Bhatia","year":"2008","unstructured":"Bhatia KS, Ismail MM, Sahdev A, et al. 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation. Clin Endocrinol Oxf. 2008;69:181\u20138.","journal-title":"Clin Endocrinol Oxf."},{"key":"8220_CR71","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2967\/jnumed.108.058701","volume":"50","author":"GA Wiseman","year":"2009","unstructured":"Wiseman GA, Pacak K, O\u2019Dorisio MS, et al. Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial. J Nucl Med. 2009;50:1448\u201354.","journal-title":"J Nucl Med."},{"key":"8220_CR72","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1210\/jc.2009-1248","volume":"94","author":"HJ Timmers","year":"2009","unstructured":"Timmers HJ, Chen CC, Carrasquillo JA, et al. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET, and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2009;94:4757\u201367.","journal-title":"J Clin Endocrinol Metab."},{"key":"8220_CR73","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-0031-1299712","volume":"44","author":"HJ Timmers","year":"2012","unstructured":"Timmers HJ, Taieb D, Pacak K. Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma. Horm Metab Res. 2012;44:367\u201372.","journal-title":"Horm Metab Res."},{"key":"8220_CR74","doi-asserted-by":"crossref","unstructured":"Rao D, van Berkel A, Piscaer I, et al. Impact of 123 I-MIBG scintigraphy on clinical decision making in pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2019;104:3812\u201320.","DOI":"10.1210\/jc.2018-02355"},{"key":"8220_CR75","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/djs188","volume":"104","author":"HJ Timmers","year":"2012","unstructured":"Timmers HJ, Chen CC, Carrasquillo JA, et al. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. J Natl Cancer Inst. 2012;104:700\u20138.","journal-title":"J Natl Cancer Inst."},{"key":"8220_CR76","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/1754-9485.12620","volume":"61","author":"A Tiwari","year":"2017","unstructured":"Tiwari A, Shah N, Sarathi V, et al. Genetic status determines (18)F-FDG uptake in pheochromocytoma\/paraganglioma. J Med Imaging Radiat Oncol. 2017;61:745\u201352.","journal-title":"J Med Imaging Radiat Oncol."},{"key":"8220_CR77","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12022-012-9199-6","volume":"23","author":"S Nolting","year":"2012","unstructured":"Nolting S, Grossman AB. Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies. Endocr Pathol. 2012;23:21\u201333.","journal-title":"Endocr Pathol."},{"key":"8220_CR78","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00259-012-2215-8","volume":"39","author":"D Taieb","year":"2012","unstructured":"Taieb D, Timmers HJ, Hindie E, et al. EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2012;39:1977\u201395.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8220_CR79","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.anorl.2016.10.003","volume":"134","author":"JP Guichard","year":"2017","unstructured":"Guichard JP, Fakhry N, Franc J, Herman P, Righini CA, Taieb D. Morphological and functional imaging of neck paragangliomas. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134:243\u20138.","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis."},{"key":"8220_CR80","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","volume":"21","author":"I Janssen","year":"2015","unstructured":"Janssen I, Blanchet EM, Adams K, et al. Superiority of [68\u00a0Ga]-DOTATATE PET\/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma. Clin Cancer Res. 2015;21:3888\u201395.","journal-title":"Clin Cancer Res."},{"key":"8220_CR81","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00259-016-3357-x","volume":"43","author":"I Janssen","year":"2016","unstructured":"Janssen I, Chen CC, Millo CM, et al. PET\/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT\/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2016;43:1784\u201391.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8220_CR82","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/RLU.0000000000001674","volume":"42","author":"H Jing","year":"2017","unstructured":"Jing H, Li F, Wang L, et al. Comparison of the 68\u00a0Ga-DOTATATA PET\/CT, FDG PET\/CT, and MIBG SPECT\/CT in the evaluation of suspected primary pheochromocytomas and paragangliomas. Clin Nucl Med. 2017;42:525\u20139.","journal-title":"Clin Nucl Med."},{"key":"8220_CR83","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40644-016-0084-2","volume":"16","author":"CA Chang","year":"2016","unstructured":"Chang CA, Pattison DA, Tothill RW, et al. (68)Ga-DOTATATE and (18)F-FDG PET\/CT in paraganglioma and pheochromocytoma: utility, patterns, and heterogeneity. Cancer Imaging. 2016;16:22.","journal-title":"Cancer Imaging"},{"key":"8220_CR84","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2967\/jnumed.118.211706","volume":"60","author":"S Han","year":"2018","unstructured":"Han S, Suh CH, Woo S, Kim YJ, Lee JJ. Performance of (68)Ga-DOTA-conjugated somatostatin receptor targeting peptide PET in detection of pheochromocytoma and paraganglioma: a systematic review and meta-analysis. J Nucl Med. 2018;60:369\u201376.","journal-title":"J Nucl Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08220-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-020-08220-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08220-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:06:44Z","timestamp":1614384404000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-020-08220-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,28]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["8220"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08220-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,28]]},"assertion":[{"value":"7 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Yang\u2019s research is supported by the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (K08HL145139). The remaining authors have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}